Newsroom

Sorted by: Latest

-

Mill Point Capital Completes the Sale of Verinext

DULUTH, Ga.--(BUSINESS WIRE)--Mill Point Capital LLC (“Mill Point”), a private equity firm focused on control investments in middle-market companies in North America across the Business Services, Industrials and IT Services sectors, announced today the sale of Verinext Corp. (“Verinext” or the “Company”), a leading IT services platform providing end-to-end technology solutions for mid-market and enterprise clients, to Arctiq, Inc. (“Arctiq”), a leading provider of professional IT solutions and...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 03.02.2026 FAPR.LN IE000WX2HZQ7  150,002.00 USD   3,675,436.48   24.503  ...
-

Samenvatting: Chinese NMPA keurt de MSI Detection Kit van Promega goed als begeleidende diagnostiek voor KEYTRUDA®

MADISON, Wis.--(BUSINESS WIRE)--De NMPA (National Medical Products Administration) heeft de OncoMate® Microsatellite Instability (MSI) Detection Kit goedgekeurd als een in vitro diagnostisch medisch hulpmiddel van klasse III in China. Het is bedoeld voor gebruik als een begeleidende diagnostiek om patiënten met vaste MSI-H (MSI-High) tumoren te identificeren voor behandeling met KEYTRUDA® (pembrolizumab), de anti-PD-1-therapie van Merck & Co., Inc., Rahway, NJ, USA. Dit is de eerste begelei...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 03.02.2026 QMAR.LN IE0006S0EBF2  100,002.00 USD   2,277,153.67   22.771  ...
-

Unstructured Achieves IL5 Authority to Operate

SAN FRANCISCO--(BUSINESS WIRE)--Unstructured today announced it has achieved an Authority to Operate (ATO) at Impact Level 5 (IL5), enabling the secure deployment of its AI-ready data platform in support of missions handling Controlled Unclassified Information (CUI). The authorization was achieved through Second Front Systems' (2F) Game Warden platform, marking a significant milestone in Unstructured’s ability to support operational artificial intelligence initiatives across defense environment...
-

RR Investors Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--RR Investors Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit with the Schall Law Firm...
-

BioSelective Capital Investments Completes Acquisition of BioDuro’s Irvine, California Drug Product Development and Manufacturing Operations

PARK CITY, Utah & IRVINE, Calif.--(BUSINESS WIRE)--BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, today announced the successful acquisition of BioDuro’s drug product development and manufacturing operations in Irvine, California, resulting in the formation of Forma Life Sciences, Inc. (FORMA), a Delaware corporation established to hold and operate the acquired assets. The transaction includes two highly accredited facilities supporting...
-

Altria to Present at the 2026 Consumer Analyst Group of New York Conference

RICHMOND, Va.--(BUSINESS WIRE)--Altria to Present at the 2026 Consumer Analyst Group of New York Conference...
-

Cognitiv Announces Strong 2025 Business Performance Driven by 388% Growth in ContextGPT

NEW YORK--(BUSINESS WIRE)--Cognitiv, the leading advanced performance partner powered by deep learning, today announced strong business momentum in 2025, highlighted by 388% growth in ContextGPT™ and the rapid adoption of the company’s deep learning advertising platform. This traction is attributed to accelerating customer growth, strategic investment in talent, and rising demand among brands and agencies for proven AI-driven performance marketing. Over the past year, marketers and media buyers...
-

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of...